TOP CORPORATE NEWS
·
Tata Power extends Tuesday's slide
Tata Power Company lost 1.48% with the stock extending recent fall
triggered by equity dilution worries after the firm said its board of directors
will meet on 27 February 2014 to consider various fund raising options.
·
Lupin receives FDA approval for
generic Mycobutin capsules
Lupin Ltd announced that it has received final approval for its
Rifabutin Capsules USP, 150 mg from the United States Food and Drugs
Administration to market a generic version of Pharmacia and Upjohn
Company’s Mycobutin Capsules 150 mg.
·
Arvind Remedies inches up after
commencement of commercial operations at a unit
Arvind Remedies rose 0.82% after the company said that on 20
February 2014 the commercial operation of the new unit of the company at
Kakkalur, Tiruvellore, Tamil Nadu for few products has been started.
·
Dr Reddy's at new high, launches
headache drug Sumatriptan
Dr Reddy’s Laboratories gained nearly 2% at Rs 2,823, after
touching a record high of 2,845 earlier in the day, after the company said it
has launched Sumatriptan Injection USP in the US.
0 comments:
Post a Comment